RSS   Newsletter   Contact   Advertise with us

VolitionRx appoints David Vanston as CFO

Staff Writer | Namur, Belgium | April 12, 2017
VolitionRxApril 12, 2017, Namur, Belgium - VolitionRx, a life sciences company, announced that David Vanston joined Volition as its new chief financial officer.
Mr. Vanston brings with him a strong background as an international finance executive and a senior controller, including extensive experience in Sarbanes-Oxley compliance and implementation of successful change programs.

Mr. Vanston has worked in a variety of sectors from manufacturing and technology to life sciences, with globally-listed companies.

Mr. Vanston has 20 years of financial management experience.

He held positions as Vice President of Excorp Medical, an early-stage company, Chief Financial Officer for GrowHow and Vice President Europe, Finance for Monster Worldwide.

Mr. Vanston managed and oversaw the accounting, finance, tax, treasury, financial planning and analysis of the business.

He is a certified chartered accountant and holds an MBA from Warwick Business School.